Women and Coronary Heart Disease

Nurse Practitioner

Volumn 26, Issue 8, 2001, Pages

  Anderson, Judith ^a   Kessenich, Cathy R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; NURSING; REVIEW; RISK FACTOR; SEXUAL DEVELOPMENT; WOMEN'S HEALTH;

CLINICAL TRIALS; CORONARY DISEASE; FEMALE; HUMANS; MALE; RISK FACTORS; SEX CHARACTERISTICS; WOMEN'S HEALTH;

EID: 0035430226     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/00006205-200108000-00002     Document Type: Article

References (42)

1. Herrington D, Reboussin D, Brosnihan, K, et al.: Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000;343(8):522-29.
2. Hulley S, Grady D, Bush T, et al.: For the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280(7):605-13.
3. American Heart Association: Heart and stroke facts: Statistical update. Dallas, Tex.: American Heart Association, 1998.
4. Castelli W: Cardiovascular disease in women. Am J Obstet Gynecol 1988;158:1553-60.
5. Sheifer S, Escarce J, Schulman K: Race and sex differences in the management of coronary artery disease. Am Heart J 2000;139:848-57.
6. Daly SC, Roger V, Leibson C, et al.: Cardiology services after stress testing: Are there sex differences? A population-based study. J Clin Epidemiol 2000;53:661-68.
7. Kennel WB, Wilson PW: Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;144:57-61.
8. Mitchell B, Hazuda H, Harrner S, et al.: Myocardial infarction in Mexican Americans and non-Hispanic whites: The San Antonio Heart Study. Circulation 1991;83:45-51.
9. Douglas PS, Ginsburg GS: The evaluation of chest pain in women. N Engl J Med 1996;334:1311-15.
10. Dorn JM, Schistermann EF, Winkelstein W, et al.: Body mass index and mortality in a general population sample of men and women: The Buffalo Health Study. Am J Epidemiol 1997;1146:919-31.
11. Garrison RJ, Higgins MW, Kannel WB: Obesity and coronary heart disease. Curr Opin Lipidol 1996;7:199-202.
12. Hennekens CH: Risk factors of coronary heart disease in women. Cardiol Clin 1998;16:1-8.
13. Kawachi I, Colditz GA, Stampfer MJ, et al.: Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med 1993;119:992-1000.
14. Pierce JP, Fiore MC, Novotny TE, et al.: Trends in cigarette smoking in the United States. Projections to the year 2000. JAMA 1989;261:61-65.
15. The Surgeon General's Report on Women and Smoking. March 27, 2001.
16. Judelson D. Gender gap: Women and coronary heart disease. Adv Nurse Pract 1999;11:43-48.
17. LaRosa JC: Triglycerides and coronary risk in women and the elderly. Arch Intern Med 1997;157:961-68.
18. Thomas JL, Braus PA: Coronary artery disease in women: A historical perspective. Arch Intern Med 1998;158:333-37.
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285.
20. National Center for Health Statistics: Health, United States 1998. Hyattsville, Md.: National Center for Health Statistics.
21. Douglas PS, Ginsburg, GS: The evaluation of chest pain in women. N Engl J Med 1996;334:1311-15.
22. Manson J, Lee I: Risk modification in the diabetic patient. In: Manson J, Ridker P, Gaziano J, et al., eds. Prevention of myocardial infarction. New York, N.Y.: Oxford University Press, Inc., 1996;241-73.
23. Rosenfeld J. Heart disease in women: Gender-specific statistics and prevention strategies for a population at risk. Postgrad Med 2000;107:111-16.
24. Wenger NK: Coronary heart disease: An older woman's major health risk. Br Med J 1997;315:1085-90.
25. Wenger N: Should women have a different risk assessment from men for primary prevention of coronary heart disease? I Women Health Gend Med 1999;8:465-67.
26. Grodstein F, Manson JE, Stampfer MJ: Postmenopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study. Ann Intern Med 2001;135(1):1-8.
27. Mosca L, Jones W, King K, et al.: Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. Arch Fam Med 2000;9:506-15.
28. Pope J, Aufderheide T, Ruthazer Ro, et al.: Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000;342:1163-70.
29. McSweeney J, Crane P: Women's prodromal and acute symptoms. Res Nurs Health 2000;23:135-46.
30. Sheifer S, Canos M, Weinfurt K, et al.: Sex differences in coronary artery size assessed by intravascular ultrasound. Am Heart J 2000;139:649-53.
31. Shlipak M, Simon J, Vittinghoff E, et al.: Estrogen and progestin, lipoprotein (a), and the risk of recurrent coronary heart disease events after menopause. JAMA 2000;283:1845-51.
32. Downs J, Clearfield M, Weis S, et al.: Primary prevention of acute coronary events with lovastatin in men and women with average cholestrol levels: Results of AFCAPS/TexCAPS. JAMA 1998;279:1615-22.
33. The Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 444 patients with CHD: The Scandinavian simvastatin survival study (4S). Lancet 1994;44:1383-89.
34. Lewis SJ, Sacks FM, Mitchell JS, et al.: Effect of pravastatin on cardiovascular events in women after myocardial infarction: The cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol 1998;32(1):140-6.
35. National Institutes of Health, National Heart, Lung, and Blood Institute: Women's Health Initiative.
36. Cerqueira M. Diagnostic testing strategies for coronary artery disease: Special issues related to gender. Am J Cardiol 1995;75:52D-60D.
37. Hansen D, Crabbe D, Rubin S: Lower diagnostic accuracy of thallium-2ol SPCT myocardial perfusion imaging in women: An effect of smaller chamber size. J Am Coll Cardiol 1996;28:1214-19.
38. Shapiro S, Slone D, Rosenberg L, et al.: Oral contraceptive use in relation to myocardial infarction. Lancet 1979;1:743-47.
39. Grodstein F, Stampfer J, Colditz G, et al.: Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1169-75.
40. Stampfer M, Colditz G: Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiological evidence. Prev Med 1991;20:47-63.
41. Barrett Connor E, Wenger N, Grady D, et al.: Hormone and nonhormone therapy for the maintenance of postmenopausal health: The need for randomized controlled trials of estrogen and raloxifene. J Womens Health 1998;7:839-47.
42. Caulin-Glaser T: Primary prevention of hypertension in women. J Clin Hypertens 2000;2(3):204-09.